Cargando…

Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson’s Disease

PURPOSE: To characterize cerebral glucose metabolism associated with different cognitive states in Parkinson’s disease (PD) using (18)F-fluorodeoxyglucose (FDG) and Positron Emission Tomography (PET). METHODS: Three groups of patients were recruited in this study including PD patients with dementia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Yilin, Ge, Jingjie, Liu, Fengtao, Wu, Ping, Guo, Sisi, Liu, Zhenyang, Wang, Yixuan, Wang, Ying, Ding, Zhengtong, Wu, Jianjun, Zuo, Chuantao, Wang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827825/ https://www.ncbi.nlm.nih.gov/pubmed/27064684 http://dx.doi.org/10.1371/journal.pone.0152716

Ejemplares similares

Dopaminergic and Metabolic Correlations With Cognitive Domains in Non-demented Parkinson’s Disease
por: Han, Linlin, et al.
Publicado: (2021)

The metabolic brain network in patients with Parkinson's disease based on (18)F-FDG PET imaging: evaluation of neuronal injury and regeneration
por: Ge, Jingjie, et al.
Publicado: (2014)

The Parkinson's Disease Progression Neuroimaging Initiative
por: Zhu, Shiyi, et al.
Publicado: (2021)

Reproducible metabolic topographies associated with multiple system atrophy: Network and regional analyses in Chinese and American patient cohorts
por: Shen, Bo, et al.
Publicado: (2020)

Validation of abnormal glucose metabolism associated with Parkinson’s disease in Chinese participants based on 18F-fluorodeoxyglucose positron emission tomography imaging
por: Jin, Rongbing, et al.
Publicado: (2018)

Brain Functional and Structural Signatures in Parkinson’s Disease
por: Liu, Chunhua, et al.
Publicado: (2020)

Distinct cerebral (18)F-FDG PET metabolic patterns in anti-N-methyl-D-aspartate receptor encephalitis patients with different trigger factors
por: Ge, Jingjie, et al.
Publicado: (2021)

Decoding the dopamine transporter imaging for the differential diagnosis of parkinsonism using deep learning
por: Zhao, Yu, et al.
Publicado: (2022)

Metabolic network as an objective biomarker in monitoring deep brain stimulation for Parkinson’s disease: a longitudinal study
por: Ge, Jingjie, et al.
Publicado: (2020)

Use of Overlapping Group LASSO Sparse Deep Belief Network to Discriminate Parkinson's Disease and Normal Control
por: Shen, Ting, et al.
Publicado: (2019)

Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer’s dementia
por: Wang, Min, et al.
Publicado: (2020)

Optimized Cingulate Island Sign in Discriminating Dementia With Lewy Bodies From Alzheimer Disease
por: Ge, Jingjie, et al.
Publicado: (2023)

Does the Personality of Patients with Parkinson's Disease Affect the Decision to Perform Deep Brain Stimulation Surgery? A Cross-Sectional Study in a Chinese Cohort
por: Lin, Wei, et al.
Publicado: (2021)

Corrigendum to “Does the Personality of Patients with Parkinson's Disease Affect the Decision to Perform Deep Brain Stimulation Surgery? A Cross-Sectional Study in a Chinese Cohort”
por: Lin, Wei, et al.
Publicado: (2021)

Cerebral Metabolism Related to Cognitive Impairments in Multiple System Atrophy
por: Shen, Cong, et al.
Publicado: (2021)

Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia
por: Tang, Yilin, et al.
Publicado: (2023)

A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment
por: Wang, Min, et al.
Publicado: (2020)

Improved interpretation of (18)F-florzolotau PET in progressive supranuclear palsy using a normalization-free deep-learning classifier
por: Lu, Jiaying, et al.
Publicado: (2023)

Tooth loss, cognitive impairment and chronic cerebral ischemia
por: Pang, Qian, et al.
Publicado: (2020)

Characteristics of Cognitive Impairment and Their Relationship With Total Cerebral Small Vascular Disease Score in Parkinson’s Disease
por: Hou, Miaomiao, et al.
Publicado: (2022)

Effect of cerebral small vessel disease on cognitive impairment in Parkinson’s disease: a systematic review and meta-analysis
por: Wan, Huijuan, et al.
Publicado: (2022)

Associations between cognitive impairment and motor dysfunction in Parkinson's disease
por: Wang, Yi‐Xuan, et al.
Publicado: (2017)

Glucose Metabolic Brain Network Differences between Chinese Patients with Lewy Body Dementia and Healthy Control
por: Chen, Danyan, et al.
Publicado: (2018)

Deeper cerebral hypoperfusion leads to spatial cognitive impairment in mice
por: Zhou, Zhiyuan, et al.
Publicado: (2022)

Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease
por: Zhou, Hucheng, et al.
Publicado: (2019)

Functional Connectivity in Parkinson’s Disease Patients with Mild Cognitive Impairment
por: Wang, Qingguang, et al.
Publicado: (2021)

Characterization of a pathogenic variant in GBA for Parkinson’s disease with mild cognitive impairment patients
por: Jiang, Zhiqiang, et al.
Publicado: (2020)

Longitudinal Cerebral Perfusion Changes in Parkinson's Disease with Subjective Cognitive Impairment
por: Jeong, Hyeonseok S., et al.
Publicado: (2016)

Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson’s disease
por: Mao, Cheng-Jie, et al.
Publicado: (2017)

Downregulation of blood serum microRNA 29 family in patients with Parkinson’s disease
por: Bai, Xiaochen, et al.
Publicado: (2017)

Association of the serum microRNA-29 family with cognitive impairment in Parkinson's disease
por: Han, Linlin, et al.
Publicado: (2020)

Based on Tau PET Radiomics Analysis for the Classification of Alzheimer’s Disease and Mild Cognitive Impairment
por: Jiao, Fangyang, et al.
Publicado: (2023)

Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints
por: Lu, Jiaying, et al.
Publicado: (2023)

Impaired cerebral autoregulation is associated with poststroke cognitive impairment
por: Chi, Nai‐Fang, et al.
Publicado: (2020)

Cognitive Performance is Associated with Altered Cerebral Hemodynamics Assessed by Transcranial Ultrasound in Parkinson’s Disease
por: Ge, Yi-Lun, et al.
Publicado: (2022)

Impact of impaired cerebral blood flow autoregulation on cognitive impairment
por: Wang, Shaoxun, et al.
Publicado: (2022)

A Meta-Analysis of Association between Cerebral Microbleeds and Cognitive Impairment
por: Wu, Rihan, et al.
Publicado: (2014)

Dopamine transporter changes after unilateral deep brain stimulation in progressive Parkinson’s disease: a case report
por: Zhang, Huiwei, et al.
Publicado: (2014)

Ophthalmologic problems correlates with cognitive impairment in patients with Parkinson's disease
por: Zhang, Chao, et al.
Publicado: (2022)

Subjective Cognitive Complaints in Newly-Diagnosed Parkinson’s Disease With and Without Mild Cognitive Impairment
por: Pan, Chenxi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3d1o1pifph2tt2eecia1ujb5q9